Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy–Naïve patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India
Infectious Diseases: Research and Treatment · 2018
DOI: 10.1177/1178633718788870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Diseases: Research and Treatment, 2018. Verfasst von Sanjeev Sinha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Emergence of human immunodeficiency virus (HIV) drug resistance mutations prior to highly active antiretroviral therapy is a serious problem in clinical management of HIV/AIDS. Risk factors for appearance of drug resistance mutations are not known. We hypothesize that Mycobacterium tuberculosis infection may contribute to rapid emergence of such mutations in antiretroviral therapy–naïve patients.
Methods
A total of 115 patients were recruited in this study of which 75 were HIV+TB+ coinfected (group 1) and 40 were HIV+TB− (group 2). Blood samples from all the patients were collected and CD4+ cell counts; HIV-1 plasma viral load and sequencing of protease and two-third region of reverse transcriptase of HIV-1 was performed and analyzed for drug resistance pattern.
Results
For patients with HIV+TB+, 10.6% (8/75) had mutations to non-nucleoside reverse transcriptase inhibitors (NNRTIs), 4% (3/75) to nucleoside reverse transcriptase inhibitors, and only 2.6% (2/75) patients had mutations to protease inhibitors. Interestingly, for group 2 (HIV+TB−), there were only NNRTI mutations found among these patients, and only 3 patients (7.5%) had these drug-resistant mutations. Clade typing and phylogenetic tree analysis showed HIV-1 subtype C predominance in these patients.
Conclusions
Our study showed that higher percentage of HIV drug resistance mutations was found among HIV+TB+ individuals compared with tuberculosis-uninfected patients. Tuberculosis coinfection may be a risk factor for emergence of high frequency of drug resistance mutations. Studies with a larger sample size will help to confirm these findings from the Indian population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India.
- Department of Microbiology, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India.
- Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India.
Zitieren
APA
Sinha, S., Gupta, K., Khan, N. H., Mandal, D., Kohli, M., Das, B. K., & Pandey, R. M. (2018). Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy–Naïve patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India. Infectious Diseases: Research and Treatment. https://doi.org/10.1177/1178633718788870
Vancouver
Sinha S, Gupta K, Khan NH, Mandal D, Kohli M, Das BK, et al. Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy–Naïve patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India. Infectious Diseases: Research and Treatment. 2018. doi:10.1177/1178633718788870
BibTeX
@article{Sinha2018,
author = {Sinha, Sanjeev and Gupta, Kartik and Khan, Nawaid Hussain and Mandal, Dibyakanti and Kohli, Mikashmi and Das, B K and Pandey, R M},
title = {Higher Frequency of HIV-1 Drug Resistance and Increased Nucleoside Reverse Transcriptase Inhibitor Mutations among the HIV-1 Positive Antiretroviral Therapy–Naïve patients Coinfected With Mycobacterium tuberculosis Compared With Only HIV Infection in India},
journal = {Infectious Diseases: Research and Treatment},
year = {2018},
doi = {10.1177/1178633718788870}
}
EUVIMED